SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-026106
Filing Date
2022-04-29
Accepted
2022-04-29 08:45:36
Documents
2
Period of Report
2022-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1638
2 EX-24 DOCUMENT attachment1.htm EX-24 4279
  Complete submission text file 0001209191-22-026106.txt   7300
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address
Rangwala Reshma (Reporting) CIK: 0001825322 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36167 | Film No.: 22870524